Trump Administration Files Amicus Brief Siding with Pharma Against 340B in Louisiana Federal Case
The US government filed an amicus brief in a Louisiana federal 340B case siding with pharmaceutical manufacturers, arguing states cannot enforce 340B contract pharmacy protections. Combined with a Fourth Circuit ruling blocking West Virginia's 340B law, this signals coordinated erosion of state-level 340B protections that could cost CA FQHCs millions in drug discount revenue.
Primary source
National Law ReviewFQHC Talent. (2026, April 4). Trump Administration Files Amicus Brief Siding with Pharma Against 340B in Louisiana Federal Case. Primary source: National Law Review. Retrieved April 28, 2026, from https://www.fqhctalent.com/intel/us-amicus-brief-pharma-louisiana-340b
More in Legislation
Jun 1
CMS Interim Final Rule on Medicaid Work Requirements Due June 1 — Will Define Exemptions, Reporting, and Enforcement
Apr 20
HRSA 340B Rebate Model RFI — Comment Deadline April 20
Apr 20
HRSA 340B Rebate Model RFI: Comment Deadline April 20 — Possible Expansion to All IRA Drugs
Apr 20
SB 1422 Committee Hearing April 20 — Bill to Restore Full Medi-Cal for Undocumented Adults Faces Critical Gate